New research uncovers autozygosity’s impact on common disease risks

Researchers explored the associations between autozygosity, measured as the fraction of the genome in runs of homozygosity (FROH), and common diseases, focusing on populations with high consanguinity rates.

BI-765179 by Boehringer Ingelheim International for Cutaneous Squamous Cell Carcinoma (cSCC): Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

December 26, 2023

The Latest on Targeted Agents, Immunotherapy for Endometrial Cancer

Molecularly targeted therapy is proving promising for endometrial cancer. Not only are molecular tests able to group or split endometrial cancers into specific molecular groups,

July 6, 2024

Drink up but hold the sugar: Unsweetened coffee linked to weight loss, study reveals

A recent study in The American Journal of Clinical Nutrition reveals that increasing the intake of unsweetened coffee, whether caffeinated or decaffeinated, is associated with

October 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.